Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Via Benzinga · January 27, 2026
TeraWulf Inc. stock rises on positive market sentiment, with a 8.34% increase in regular trading hours; potential uptrend continuation.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
IonQ Inc. (IONQ) shares are trading higher in Tuesday's pre-market session as the company expands its quantum technology control with the acquisition of U.S. chip manufacturer SkyWater Technology Inc. (SKYT) in a deal valued at roughly $1.8 billion, SkyWater said Monday.
Via Benzinga · January 27, 2026
CoreWeave Inc (NASDAQ:CRWV) is trading higher on Tuesday after Deutsche Bank upgraded the stock from Hold to Buy and lifted its price target from $100 to $140.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor Fitzgerald. The firm raised its target to $27 from $24, providing a catalyst for the pharmaceutical giant even as the broader Healthcare sector declined 1.6% during the session.
Via Benzinga · January 27, 2026
Maplebear Inc. stock falls as Amazon expands grocery delivery, despite Instacart's new partnerships with retail tech and loyalty strategy.
Via Benzinga · January 27, 2026
Biomx shares are surging Tuesday afternoon following a 13D filing that disclosed Pyu Pyu Capital's acquisition of a 19.99% stake in the company.
Via Benzinga · January 27, 2026
Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, outperforming Pfizer's Litfulo in a severe hair loss mouse model.
Via Benzinga · January 27, 2026
Affirm shares initially traded higher on a new Bolt BNPL partnership and analyst upgrade, though the stock later trimmed its gains.
Via Benzinga · January 27, 2026
FDA removes the clinical hold on Intellia's Phase 3 trial for a rare nerve disease after safety updates, while review continues for its heart disease program.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved Ryoncil, as the company expands hospital access and prepares an adult trial.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Wall Street regained momentum on Tuesday as upbeat corporate earnings lifted risk appetite, pushing the S&P 500 to fresh all-time highs and driving the Nasdaq 100 closer to its prior October record.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Kazia Therapeutics shared clinical update on Phase 1b study of paxalisib for late-stage metastatic TNBC. Encouraging responses observed.
Via Benzinga · January 27, 2026
Genenta plans a major shift into defense businesses, backing weapons maker ATC, rebranding as Saentra Forge and reshaping its future as shares see sharp moves.
Via Benzinga · January 27, 2026
Warren Buffett unveiled a purchase in UNH stock in 2025. The position could be costing Berkshire Hathaway in 2026.
Via Benzinga · January 27, 2026
Shares of Northrop Grumman Corporation (NASDAQ: NOC) are up Tuesday after the defense company reported quarterly earnings that showed a backlog of $95.7 billion for next-generation defense systems.
Via Benzinga · January 27, 2026
CGI announced a global go-to-market alliance with OpenAI to help regulated enterprises deploy AI securely at scale.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Bitcoin (CRYPTO: BTC) has remained locked in a tight range for nearly 60 days, with selling pressure preventing a sustained move higher.
Via Benzinga · January 27, 2026
U.S. shutdown risk rises as DHS funding talks stall ahead of Jan. 30 deadline. Polymarket odds jump to 79% as markets recall uneven sector moves last time.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Michael Burry sees GameStop as more than a struggling retailer— he sees a $4 billion war chest led by visionary Ryan Cohen.
Via Benzinga · January 27, 2026
Oscar Health Inc (NYSE: OSCR) shares are trading lower Tuesday morning as investors react to a surprise Medicare Advantage update from the Trump administration.
Via Benzinga · January 27, 2026
Union Pacific Corporation (NYSE: UNP) reports Q4 2025 financial results with $1.8B net income, missing analyst estimates. Operational efficiency improved.
Via Benzinga · January 27, 2026
Counterpoint Research says big tech companies like Alphabet (Google), Amazon, Microsoft and Apple are rapidly expanding custom AI chips to power data centers, with shipments expected to triple by 2027 as demand for faster, more efficient AI grows.
Via Benzinga · January 27, 2026
Redwire Corporation (NYSE: RDW) shares are trading higher Tuesday after the company announced it secured a Missile Defense Agency contract.
Via Benzinga · January 27, 2026
Trade Desk Inc. (TTD) stock fell after CFO termination. Analysts cite concerns over leadership and reduced price forecast.
Via Benzinga · January 27, 2026
YFM Equity Partners, Maven Capital and several other firms have invested $50 million into AI software company Summize.
Via Benzinga · January 27, 2026
From Norway to Japan, here are a few country ETFs that are trading near their 52-week highs driven by policy shifts, tech trends and macro tailwinds.
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Via Benzinga · January 27, 2026
Nvidia's $2B investment in CoreWeave is a vote of confidence in AI infrastructure, but skeptics believe it creates synthetic demand...
Via Benzinga · January 27, 2026